Apolipoprotein (apo) E and apoA-1 play several critical roles in modulating and in directing plasma lipoprotein metabolism. Dysfunction by either protein leads to increased atherosclerosis and ultimately to heart disease and stroke. In addition, apoE4 is an established risk factor for neurodegeneration and poor outcome from head injury and stroke. Despite the critical roles that apoE and apoA-1 play in normal physiology, detailed structural information is not available for either of these proteins in their natural lipid-bound state. This proposal is based on our recent technological breakthrough of crystalling apolipoprotein-phospholipid complexes and is designed to provide, for the first time, detailed structural information on apoE and apoA-I bound to lipid.
Three specific aims focus on relevant issues and questions related to the structure and function of apoE and apoA-I. 1. The structures of apoE-dimyristoylphosphatidylcholine (DMPC) complexes will be determined to ascertain how lipid association influences apoE function. 2. The hypothesis that apoA-1 adopts the so-called """"""""belt model"""""""" conformation on a phospholipid disc will be tested and structural details on the interaction of apoA-1 amphipathic helices with lipid and insights into LCAT activation will be provided. 3. To analyze the effect of cholesterol incorporation into phospholipid discoidal particles on the structure of apoE and apoA-1. These studies will provide novel structural information on the effect of lipid association on the structure and function of apoE and apoA-1 and provide, for the first time, insights into how these proteins function in their natural lipid-associated state.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL064963-04
Application #
6638664
Study Section
Metabolism Study Section (MET)
Program Officer
Srinivas, Pothur R
Project Start
2000-04-01
Project End
2005-03-31
Budget Start
2003-04-01
Budget End
2005-03-31
Support Year
4
Fiscal Year
2003
Total Cost
$378,831
Indirect Cost
Name
J. David Gladstone Institutes
Department
Type
DUNS #
099992430
City
San Francisco
State
CA
Country
United States
Zip Code
94158
Peters-Libeu, Clare; Miller, Jason; Rutenber, Earl et al. (2012) Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure. J Mol Biol 421:587-600
Peters-Libeu, Clare A; Newhouse, Yvonne; Hall, Steven C et al. (2007) Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution. J Lipid Res 48:1035-44
Peters-Libeu, Clare A; Newhouse, Yvonne; Hatters, Danny M et al. (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281:1073-9
Newhouse, Yvonne; Peters-Libeu, Clare; Weisgraber, Karl H (2005) Crystallization and preliminary X-ray diffraction analysis of apolipoprotein E-containing lipoprotein particles. Acta Crystallogr Sect F Struct Biol Cryst Commun 61:981-4
Zabalawi, Manal; Bhat, Shaila; Loughlin, Tara et al. (2003) Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. Am J Pathol 163:1201-13
Li, Hui-Hua; Lyles, Douglas S; Pan, Wei et al. (2002) ApoA-I structure on discs and spheres. Variable helix registry and conformational states. J Biol Chem 277:39093-101
Sorci-Thomas, Mary G; Thomas, Michael J (2002) The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 12:121-8
Li, H H; Thomas, M J; Pan, W et al. (2001) Preparation and incorporation of probe-labeled apoA-I for fluorescence resonance energy transfer studies of rHDL. J Lipid Res 42:2084-91